The Japanese journal of surgery

, Volume 21, Issue 1, pp 14–24 | Cite as

The significance of serum mitochondrial aspartate aminotransferase activity in the surgical field

  • Eishin Sada
  • Seiki Tashiro
  • Yoshimasa Morino
Original Articles


A study was carried out on the clinical significance of changes in the serum level of mitochondrial aspartate aminotransferase before and after surgery on patients suffering from varous hepato-biliary diseases. The patients included those whose livers were impaired with cirrhosis, jaundice, or direct surgical intervention such as hepatectomy. It was found that the postoperative liver function of patients whose preoperative values of serum mitochondrial aspartate aminotransferase had been less than 10 Karmen units recovered with a favorable course, whereas that of patients whose values had exceeded 20 units deteriorated with persistent jaundice, ascites or hepatic insufficiency. Both the sensitivity and specificity of respective liver function tests were examined by the preoperative values of routine liver function tests and the postoperative liver functions. The results revealed the serum value of mitochondrial aspartate aminotransferase to be more sensitive than the other tests, while specificity was not significantly different. A safety limit for a favorable postoperative course in terms of liver function was observed in patients showing a preoperative serum mitochondrial aspartate aminotransferase activity of below 10 units. Thus, serum mitochondrial aspartate aminotransferase activity could be applied as a useful marker for hepato-biliary surgery.

Key Words

mitochondrial aspartate aminotransferase liver function test hepato-biliary surgery 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ozawa K, Takasan H, Kitamura O, Mizukami T, Kamano T, Takeda H, Ohsawa T, Murata T, Honjo I. Effect of portal vein on liver mitochondrial metabolism. J Biochem 1971; 70: 755–764.PubMedGoogle Scholar
  2. 2.
    Ozawa K, Kitamura O, Mizukami T, Yamaoka Y, Kamano T, Takeda H, Takasan H, Honjo I. Human liver mitochondria. Clin Chim Acta 1972; 38: 385–393.PubMedCrossRefGoogle Scholar
  3. 3.
    Noguchi T, Mizumoto R. Estimation of operative risk and selection of operative procedures in liver surgery. Nippon Shokaki Geka Gakkai Zasshi (Jpn J Gastroenterol Surg) 1982; 15: 717–721. (in Japanese)Google Scholar
  4. 4.
    Shintani K, Fujiwara T, Kobayashi O, Morita T, Kaneyuki T, Nakano H. Surgery in hepatic dysfunction and preoperative estimation of surgical risk. Nippon Shokaki Geka Gakkai Zasshi (Jpn J Gastroenterol Surg) 1982; 15: 1442–1448. (in Japanese)Google Scholar
  5. 5.
    Wróblewski F, LaDue JS. Serum glutamic oxalacetic transaminase activity as an index of liver cell injury: A preliminary report. Ann Intern Med 1955; 43: 345–359.PubMedGoogle Scholar
  6. 6.
    Craver WL, Johnson G, Beal JM. Alterations in serum glutamic-oxalacetic transaminase activity following operations. Surg Forum 1957; 8: 77–80.PubMedGoogle Scholar
  7. 7.
    Wróblewski F. The clinical significance of transaminase activities of serum. Amer J Med 1959; 27: 911–923.PubMedCrossRefGoogle Scholar
  8. 8.
    Kodama M, Tanaka T, Kodama O, Harada M, Takeuchi H, Itoh N. Indications and problems for gastroenterological surgery in patients with hepatic dysfunction—Special reference to the evaluation of routine liver function tests. Nippon Shokaki Geka Gakkai Zasshi (Jpn J Gastroenterol Surg) 1982; 15: 680–685. (in Japanese)Google Scholar
  9. 9.
    Tashiro S, Ogata K, Yamasaki K, Hayashida N, Sada E, Murata E, Hiraoka T. Surgery in patients with hepatic dysfunction. Nippon Shokaki Geka Gakkai Zasshi (Jpn J Gastroenterol Surg) 1982; 15: 686–692. (in Japanese)Google Scholar
  10. 10.
    Kamei S, Okubo A, Mori S, Sasaoka S, Iwasaki Y, Kawano N. Serum COT isozymes for evaluation of hepatic diseases. Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol) 1977; 74: 1539–1546. (in Japanese with English Abst.)PubMedGoogle Scholar
  11. 11.
    Nalpas B, Vassault A, Guillou AL, Lesgourgues B, Ferry N, Lacour B, Berthelot P. Serum activity of mitochondrial aspartate aminotransferase: A sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatology 1984; 4: 893–896.PubMedCrossRefGoogle Scholar
  12. 12.
    Sada E, Tashiro S, Morino Y. The significance of serum mitochondrial aspartate aminotransferase activity in obstructive jaundice: Experimental and clinical studies. Jpn J Surg 1990; 20: 392–405.PubMedCrossRefGoogle Scholar
  13. 13.
    Konno T, Maeda H, Iwai K, Tashiro S, Maki S, Morinaga T, Mochinaga M, Hiraoka T, Yokoyama I. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Cancer Clin Oncol 1983; 19: 1053–1065.PubMedCrossRefGoogle Scholar
  14. 14.
    Wada H, Teranishi H, Kagamiyama H, Ohyanagi H, Shirakawa M, Mitsuno T, Fuse K, Sawada Y. A simple immunological method for differential determination of serum glutamic-oxalocacetic transaminase isoenzymes. (I) Using anti-human-COT antibody. Med J Osaka Univ 1978; 29: 181–190.PubMedGoogle Scholar
  15. 15.
    Teranishi H, Wada H, Sawada Y. A simple immunological method for differential determination of serum glutamic-oxaloacetic transaminase isoenzymes. (II) Using anti-pig-GOT antibody. Med J Osaka Univ 1978; 29: 191–198.PubMedGoogle Scholar
  16. 16.
    Karmen A, Wróblewski F, LaDue JS. Transaminase activity in human blood. J Clin Invest 1955; 34: 126–131.PubMedCrossRefGoogle Scholar
  17. 17.
    Malloy HT, Evelyn KA. The determination of bilirubin with the photoelectric colorimeter. J Biol Chem 1937; 119: 481–490.Google Scholar
  18. 18.
    Doumas BT, Watson W. ARD, Giggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 1971; 31: 87–96.PubMedCrossRefGoogle Scholar
  19. 19.
    Ozawa K, Ida T, Yamada T, Yamaoka Y, Takasan H, Honjo I. Oral glucose tolerance in patients with jaundice. Surg Gynecol Obstet 1975; 140: 582–588.PubMedGoogle Scholar
  20. 20.
    Lindenmuth WW, Eisenberg MM. The surgical risk in cirrhosis of the liver. Arch Surg 1963; 86: 235–242.PubMedGoogle Scholar
  21. 21.
    Hunton DB, Bollman JL, Hoffman HN. II: Studies of hepatic function with indocyanine green. Gastroenterology 1960; 39: 713–723.PubMedGoogle Scholar
  22. 22.
    Moody FG, Rikkers LF, Aldrete JS. Estimation of the functional reserve of human liver. Ann Surg 1974; 180: 592–598.PubMedGoogle Scholar
  23. 23.
    Person DA, Judge RD. Effect of operation on serum transaminase levels. Arch Surg 1958; 77: 892–897.Google Scholar
  24. 24.
    Kamimoto Y. Studies on mechanism of plasma clearance of serum enzymes.—Fate of GOT isozymes injected intravenously into rat— Kumamoto Igakkai Zasshi (J Kumamoto Med Soc) 1984; 58: 30–36. (in Japanese with English Abst.)Google Scholar
  25. 25.
    LaDue JS, Wróblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science 1954; 120: 497–499.PubMedGoogle Scholar
  26. 26.
    Judah JD, Ahmed K, Mclean AEM. Pathogenesis of cell necrosis. Fed Proc 1965; 24: 1217–1221.PubMedGoogle Scholar
  27. 27.
    Nalpas B, Vassult A, Charpin S, Lacour B, Berthelot P. Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: Diagnostic value and interpretation in a liver unit. Hepatology 1986; 6: 608–614.PubMedGoogle Scholar

Copyright information

© The Japan Surgical Society 1991

Authors and Affiliations

  • Eishin Sada
    • 1
  • Seiki Tashiro
    • 1
  • Yoshimasa Morino
    • 2
  1. 1.The First Department of SurgeryKumamoto University Medical SchoolKumamotoJapan
  2. 2.Second Department of BiochemistryKumamoto University Medical SchoolKumamotoJapan

Personalised recommendations